Literature DB >> 7688826

Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.

C Wang1, K Takeuchi, L H Pinto, R A Lamb.   

Abstract

The influenza A virus M2 integral membrane protein has ion channel activity which can be blocked by the antiviral drug amantadine. The M2 protein transmembrane domain is highly conserved in amino acid sequence for all the human, swine, equine, and avian strains of influenza A virus, and thus, known amino acid differences could lead to altered properties of the M2 ion channel. We have expressed in oocytes of Xenopus laevis the M2 protein of human influenza virus A/Udorn/72 and the avian virus A/chicken/Germany/34 (fowl plague virus, Rostock) and derivatives of the Rostock ion channel altered in the presumed pore region. The pH of activation of the M2 ion channels and amantadine block of the M2 ion channels were investigated. The channels were found to be activated by pH in a similar manner but differed in their apparent Kis for amantadine block.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688826      PMCID: PMC237962     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.

Authors:  K Martin; A Helenius
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

2.  Nucleotide sequences of influenza A virus RNA segment 7: a comparison of five isolates.

Authors:  S L Zebedee; R A Lamb
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

Review 3.  Tetraethylammonium ions and the potassium permeability of excitable cells.

Authors:  P R Stanfield
Journal:  Rev Physiol Biochem Pharmacol       Date:  1983       Impact factor: 5.545

4.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

5.  Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins.

Authors:  R A Lamb; C J Lai; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

6.  Maturation of influenza A virus hemagglutinin--estimates of the pH encountered during transport and its regulation by the M2 protein.

Authors:  S Grambas; A J Hay
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

7.  Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles.

Authors:  D A Steinhauer; S A Wharton; J J Skehel; D C Wiley; A J Hay
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

8.  Influenza virus uncoating in infected cells and effect of rimantadine.

Authors:  A G Bukrinskaya; N K Vorkunova; G V Kornilayeva; R A Narmanbetova; G K Vorkunova
Journal:  J Gen Virol       Date:  1982-05       Impact factor: 3.891

9.  Influenza virus M2 protein: a molecular modelling study of the ion channel.

Authors:  M S Sansom; I D Kerr
Journal:  Protein Eng       Date:  1993-01

10.  On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride.

Authors:  J J Skehel; A J Hay; J A Armstrong
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

View more
  202 in total

1.  Definitive assignment of proton selectivity and attoampere unitary current to the M2 ion channel protein of influenza A virus.

Authors:  T I Lin; C Schroeder
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus.

Authors:  D Salom; B R Hill; J D Lear; W F DeGrado
Journal:  Biochemistry       Date:  2000-11-21       Impact factor: 3.162

3.  Transmembrane domain of M2 protein from influenza A virus studied by solid-state (15)N polarization inversion spin exchange at magic angle NMR.

Authors:  Z Song; F A Kovacs; J Wang; J K Denny; S C Shekar; J R Quine; T A Cross
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

4.  Structure of the transmembrane region of the M2 protein H(+) channel.

Authors:  J Wang; S Kim; F Kovacs; T A Cross
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

5.  Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus.

Authors:  K Tobler; M L Kelly; L H Pinto; R A Lamb
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity.

Authors:  T Watanabe; S Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

7.  Influence of an additional amino group on the potency of aminoadamantanes against influenza virus A. II - Synthesis of spiropiperazines and in vitro activity against influenza A H3N2 virus.

Authors:  Christos Fytas; Antonios Kolocouris; George Fytas; Grigoris Zoidis; Charalampos Valmas; Christopher F Basler
Journal:  Bioorg Chem       Date:  2010-09-21       Impact factor: 5.275

8.  Analysis of the pore structure of the influenza A virus M(2) ion channel by the substituted-cysteine accessibility method.

Authors:  K Shuck; R A Lamb; L H Pinto
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

9.  Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses.

Authors:  Rafal M Pielak; Kirill Oxenoid; James J Chou
Journal:  Structure       Date:  2011-11-09       Impact factor: 5.006

10.  The Influenza M2 Ectodomain Regulates the Conformational Equilibria of the Transmembrane Proton Channel: Insights from Solid-State Nuclear Magnetic Resonance.

Authors:  Byungsu Kwon; Mei Hong
Journal:  Biochemistry       Date:  2016-09-12       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.